nach oben

Erschienen in:

10.10.2019 | Editorial

^99mTc-aprotinin imaging in cardiac amyloidosis. Make an old tool new again?

verfasst von: Riemer H. J. A. Slart, MD, PhD, Andor W. J. M. Glaudemans, MD, PhD, Walter Noordzij, MD, PhD, Hans L. A. Nienhuis, MD, PhD, Bouke P. C. Hazenberg, MD, PhD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Excerpt

Cardiac amyloidosis (CA) or amyloid cardiomyopathy (ACM), resulting from extracellular deposition of amyloid fibrils, is an underestimated cause of heart failure and cardiac arrhythmias.1,2 Amyloid cardiomyopathy is a restrictive form of cardiomyopathy (CM) characterized by diastolic dysfunction and should be suspected in any patient presented with heart failure with preserved ejection fraction (HFpEF). The two main types of cardiac amyloidosis are AL-type, derived from misfolded immunoglobulin light chains, and ATTR-type, derived from misfolded transthyretin (TTR) protein. …

Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circulation 2017;135:1357-77.CrossRef

Gonzalez-Lopez E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 2015;36:2585-94.CrossRef

Maleszewski JJ. Cardiac amyloidosis: Pathology, nomenclature, and typing. Cardiovasc Pathol 2015;24:343-50.CrossRef

Manolis AS, Manolis AA, Manolis TA, Melita H. Cardiac amyloidosis: An underdiagnosed/underappreciated disease. Eur J Intern Med 2019;67:1-13.CrossRef

Lane T, Fontana M, Martinez-Naharro A, Quarta CC, Whelan CJ, Petrie A, et al. Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis. Circulation 2019;140:16-26.CrossRef

Slart RHJA, Glaudemans AWJM, Noordzij W, Bijzet J, Hazenberg BPC, Nienhuis HLA. Time for new imaging and therapeutic approaches in cardiac amyloidosis. Eur J Nucl Med Mol Imaging 2019;46(7):1402-6.CrossRef

Aprile C, Marinone G, Saponaro R, Bonino C, Merlini G. Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin. Eur J Nucl Med 1995;22:1393-401.CrossRef

Han S, Chong V, Murray T, McDonagh T, Hunter J, Poon FW, Gray HW, Neilly JB. Preliminary experience of 99mTc-Aprotinin scintigraphy in amyloidosis. Eur J Haematol 2007;79:494-500.CrossRef

Cardoso I, Pereira PJ, Damas AM, Saraiva MJ. Aprotinin binding to amyloid fibrils. Eur J Biochem 2000;267:2307-11.CrossRef

10.

Gölker CF, Whiteman MD, Gugel KH, Gilles R, Stadler P, Kovatch RM, et al. Reduction of the infectivity of scrapie agent as a model for BSE in the manufacturing process of Trasylol. Biologicals 1996;24:103-11.CrossRef

11.

Awaya T, Minamimoto R, Iwama K, Kubota S, Hotta M, Hirai R, Yamamoto M1, Okazaki O1, Hara H, Hiroi Y, Hiroe M, Moroi M, Performance of 99mTc-aprotinin scintigraphy for diagnosing light chain (AL) cardiac amyloidosis confirmed by endomyocardial biopsy. J Nucl Cardiol 2019.

12.

Kim YJ, Ha S, Kim YI. Cardiac amyloidosis imaging with amyloid positron emission tomography: A systematic review and meta-analysis. J Nucl Cardiol 2018. https://doi.org/10.1007/s12350-018-1365-x.CrossRefPubMedPubMedCentral

13.

Antoni G, Lubberink M, Estrada S, et al. In vivo visualization of amyloid deposits in the heart with ¹¹C-PIB and PET. J Nucl Med 2013;54:213-20.CrossRef

14.

Park MA, Padera RF, Belanger A, Dubey S, Hwang DH, Veeranna V, et al. 18F-florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: Autoradiography study. Circ Cardiovasc Imaging 2015. https://doi.org/10.1161/CIRCIMAGING.114.002954.CrossRefPubMedPubMedCentral

15.

Minamimoto R, Awaya T, Iwama K, Hotta M, Nakajima K, Hirai R, Okazaki O, Hiroi Y. Significance of 11C-PIB PET/CT in cardiac amyloidosis compared with 99mTc-aprotinin scintigraphy: A pilot study. J Nucl Cardiol 2018. https://doi.org/10.1007/s12350-018-1260-5.CrossRefPubMed

16.

Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study. Ann Intern Med 2004;140:85-93.CrossRef

17.

Manwani R, Page J, Lane T, Burniston M, Skillen A, Lachmann HJ, et al. A pilot study demonstrating cardiac uptake with 18F-florbetapir PET in AL amyloidosis patients with cardiac involvement. Amyloid 2018;25:247-52.CrossRef

Titel: 99mTc-aprotinin imaging in cardiac amyloidosis. Make an old tool new again?
verfasst von: Riemer H. J. A. Slart, MD, PhD
Andor W. J. M. Glaudemans, MD, PhD
Walter Noordzij, MD, PhD
Hans L. A. Nienhuis, MD, PhD
Bouke P. C. Hazenberg, MD, PhD
Publikationsdatum: 10.10.2019
Verlag: Springer International Publishing
Erschienen in: Journal of Nuclear Cardiology / Ausgabe 4/2020
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-019-01917-3

Neu im Fachgebiet Kardiologie

16.04.2024 | Chronische Herzinsuffizienz | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

^99mTc-aprotinin imaging in cardiac amyloidosis. Make an old tool new again?

Excerpt

Neu im Fachgebiet Kardiologie

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Selbstexpandierende TAVI-Klappen bei kleinem Aortenanulus im Vorteil

Verbesserung der HDL-Funktion als Lipidtherapie floppt in Mega-Studie

Update Kardiologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Novel markers of coronary inflammation in patients with type 2 diabetes

Two-hour postload plasma glucose and pigment epithelium-derived factor levels are markers of coronary artery inflammation in type 2 diabetic patients

Right-sided endocarditis on Contegra tube in a complex cianotic congenital heart disease

Cardiac uptake patterns in routine 18F-FDG PET-CT scans: A pictorial review

Correction to: Aortic valve and coronary 18F-sodium fluoride activity: a common cause?

Correction to: Staged testing as a solution to the challenges of testing lower risk patients

Neu im Fachgebiet Kardiologie

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Selbstexpandierende TAVI-Klappen bei kleinem Aortenanulus im Vorteil

Verbesserung der HDL-Funktion als Lipidtherapie floppt in Mega-Studie

Update Kardiologie